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ABSTRACT OF THESIS 
 
 
EFFECTS OF METHOPRENE ON THE SURVIVORSHIP  
AND FECUNDITY OF ADULT AEDES MOSQUITOES: A STRATEGY FOR 
INACTIVATING RELEASED MOSQUITOES 
 
Methoprene is a Juvenile Hormone (JH) analogue commonly used for the control 
of mosquito larvae.  When applied to a mosquito breeding site, methoprene enters the 
haemolymph, where it mimics the function of JH and interferes with normal 
metamorphosis, resulting in larval mortality. Methoprene is commonly used for the 
control of larvae and has not been used as an adulticide, due to an absence of acute 
effects.  This study evaluated possible chronic effects caused by the exposure of adult 
Aedes mosquitoes to methoprene. Methoprene was applied, in both technical grade and 
the commercially available Altosid®, topically to adults through droplet application on 
the abdomen and as a spray application. Mosquitoes were examined for treatment effects 
on ovary development, adult male and female mortality, and fecundity.  The results 
demonstrate that relatively high doses are required to affect adult survivorship.  In 
contrast, significant impacts on both fecundity and egg hatch were observed for females 
treated at the lower dosages. I discuss the results in relation to autocidal strategies for 
mosquito control in which the release of fecund females is to be avoided. 
KEYWORDS: Aedes, Methoprene, Insect Growth Regulator, Fecundity, Vitellogenesis 
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Chapter One 
Introduction 
 The Wolbachia biopesticide approach uses repeated, inundative releases of male 
mosquitoes to control populations of mosquitoes.  A biopesticide is defined as the 
application of a microorganism with the purpose of control or suppression of a pest 
species (Hynes and Boyetchko 2005).  Prior examples of this method include the use of 
Bacillus thurengiensis isrealensis (Bti) for the control of mosquito larvae, where granules 
containing the crystalline toxins created by the Bti bacteria are used to treat mosquito 
breeding sites (Boisvert and Boisvert 2000). The Wolbachia biopesticide treatment 
differs from other biopesticide applications by the use of infected mosquitoes to carry the 
microorganism to the target mosquito species.  Released mosquitoes have been 
artificially infected in the laboratory with an obligate intracellular bacterial symbiont 
called Wolbachia (Atayame et al. 2011).  When a male mosquito carrying a novel strain 
of Wolbachia mates with a wild female mosquito that does not carry the same Wolbachia 
infection, the female becomes incapable of producing offspring due to a mechanism 
called Cytoplasmic Incompatibility (CI) (Brelsfoard et al. 2009).  CI causes karyogamy 
failure and arrested embryonic development, preventing the production of offspring 
(Werren 1997). By increasing the number of incompatible mating, the Wolbachia bio-
pesticide method leads to mosquito population suppression (Dobson 2003). 
 For this method to effectively reduce the numbers of wild mosquitoes, a large 
number of male mosquitoes must be released.  In laboratory trials, this number has been 
determined to be approximately 15 times the number of mosquitoes in the wild 
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population (Mains 2012). Release of fertile females is to be avoided, not only because 
they can transmit disease but also because this can cause population replacement. Fertile 
Wolbachia-infected females would be able to mate successfully with the released males.  
This gives the accidentally released females a reproductive advantage and ability to 
displace wild populations (Xi et al 2005).  In this case, continuing to release males 
infected with the same Wolbachia infection type will no longer have any effect on the 
mosquito population, due to the presence of the infected females.  
 To prevent the release of infected females, methods have been created to separate 
male and female mosquitoes as pupae in the laboratory prior to release. This method is 
effective, though not perfect.  It is possible for female mosquitoes to be missed, and 
samples must be sorted by hand in order to confirm that no female mosquitoes are 
mistakenly released (Mains 2012).  This process is slow and time inefficient.  There is a 
need for a more rapid and efficient method of assuring that population replacement does 
not occur.   
 One potential method of preventing accidental population replacement is to 
ensure that any females that are released are incapable of producing offspring.  One could 
ensure this by performing a chemical treatment which specifically targets female 
mosquitoes while not affecting males.  This treatment would focus on the physiology of 
the adult female mosquito and prevent the mosquito from reproducing.  For a chemical 
treatment to be successful, the treatment cannot have a negative effect on male 
mosquitoes.  The Wolbachia bio-pesticide approach functions by increasing the numbers 
of incompatible males in the environment, and therefore relies on the released males 
surviving long enough to mate.   
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 A potential candidate for this treatment is juvenile hormone (JH). In mosquito 
physiology, JH is required during the early stages of female reproductive development 
(Klowden 2002).  This hormone controls events during previllogenic stage t (Raikhel et 
al. 2002). During vitellogenesis, oocytes develop  until they reach a resting length of 100 
µm (Noriega 2004). At this point, development of oocytes halts, until the mosquito takes 
a bloodmeal (Raikhel and Dhadialla 1992). Once the mosquito takes a bloodmeal, JH 
levels become reduced, and the ovary of the mosquito begins to secrete ecdysone 
(Raikhel 1992).  Ecdysone is the primary hormone which directs development of the 
oocytes in the ovarioles (Hagedorn 1989). In male mosquitoes, JH has been shown to be 
associated with the male accessory gland (Borovsky et al. 1994).  The mosquito male 
accessory gland is contribute proteins to seminal fluids which improves seminal retention 
in females after mating (Leopold 1976).  
 Juvenile hormone analogs (JHA) are used already in the field for the control of 
mosquitoes.  Synthetic JHA is applied to the water, for control of larval mosquitoes.  This 
synthetic JHA is a chemical known as methoprene, which has been in use since 1975 
(Csondes 2004).  While the larval mosquito develops, methoprene interferes with 
ecdysone induced gene expression, which prevents midgut remodeling in the pupal 
mosquito and kills the mosquito before it molts into adult (Wu et al. 2006). Methoprene 
has been shown to be a strong larvicide, and kills most larvae that come in contact with it 
(Norland and DeWitt 1975).   
 While the effect of methoprene on mosquito larvae is well known, little is known 
about the effects methoprene would have on adult physiology.  The purpose of this study 
is to quantify the effects of the Insect Growth Regulator (IGR) methoprene on adult 
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mosquitoes, and investigate the potential of methoprene as a method for selectively 
inactivating female mosquitoes, while leaving male mosquitoes unaffected. 
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Objectives/ specific aims 
My thesis research is focused on the development of a novel pesticide application 
using the IGR, methoprene, to lower the fecundity of female Aedes mosquitoes.  Male 
and female survivorship was also assessed to determine methoprene effects. The 
optimum treatment would also have a negligible effect on male mosquitoes. 
In respect to inundative releases, the specific aims are: 
1. Test whether methoprene application will affect male and female mortality and 
the fecundity of the model species Ae. aegypti 
2. Test for a similar effect of this method on Ae. polynesiensis and Ae. albopictus 
3. Test the application of a commercially available form of methoprene, Altosid®, 
on all three mosquito species on male and female mortality and fecundity 
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Chapter Two 
Methoprene effects on survival and reproductive performance of adult female and 
male Aedes aegypti (Diptera: Culicidae) 
Introduction 
The yellow fever mosquito, Ae. aegypti L., is the principal vector, worldwide, of 
dengue fever. Dengue affects an estimated 50-100 million people per year, resulting in 
greater than 20,000 deaths annually (Gibbons and Vaughn 2002). Currently no vaccine or 
specific therapeutic treatment for dengue exists. Novel control methods are thus sorely 
needed. Current measures against Ae. aegypti consist of breeding source reduction and 
application of chemical insecticides.  However, both strategies are complicated by the 
behavior of this vector and its use of small, dispersed, inaccessible and cryptic bodies of 
water (Gubler and Clark 1996).  
The self-delivering feature of Sterile Insect Techniques (SIT) type approaches 
make them attractive against container breeding mosquitoes, such as Ae. aegypti (Alphey 
et al. 2009).  One such approach is based on Wolbachia-induced cytoplasmic 
incompatibility and is being developed for various mosquito species (Atyame et al. 
2011). The Wolbachia biopesticide approach releases male mosquitoes which have been 
infected with a strain of symbiotic Wolbachia bacteria.  When these infected mosquitoes 
mate with wild females, the presence of the bacteria prevents the females from producing 
offspring.  With repeated releases of infected male mosquitoes over time, the wild 
population could potentially be reduced (Brelsfoard et al. 2008). 
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For applied strategies based on inundative mosquito releases, it is typical to 
remove females, leaving males only in the release materials.  This is important because 
female mosquitoes bite and transmit disease, but female releases can also represent an 
experimental complication.  For the Wolbachia biopesticide approach, the release of 
many females has the potential to establish the Wolbachia infection of the release strain 
at the release site, which could lead to compatibility with subsequent male releases 
(Dobson 2003).  For additional approaches, such as those based on transgenic 
mosquitoes, female release may be undesirable from a regulatory standpoint (Benedict 
and Robinson 2003). 
The potential of unintended female release has led to the development of methods 
for improved accuracy of sorting and removal of females from males (Catteruccia et al. 
2005).  Additional approaches are being developed for the inactivation of females, such 
that if a female is released, she is short lived and/or unable to reproduce.  An example of 
the latter is the exposure of release material to low doses of radiation, which has no 
detectible effect on males but sterilizes females (Brelsfoard et al. 2009).  Here we 
examine an additional approach, based on the pre-treatment of release material with a 
chemical that potentially affects females but not males. 
Methoprene is a Juvenile Hormone (JH) analog that was first registered as a 
biological pesticide in 1975 and has proven effective in the control of mosquito larvae 
(Norland and DeWitt 1975). Methoprene has been approved by the World Health 
Organization as relatively safe and nontoxic for humans and other vertebrates, including 
use in drinking water (Garg and Donahue 1989).  
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JH plays an important role in the regulation of development of insects. Molting 
between larval instars is initiated by ecdysone.  During the molt, the presence of high JH 
levels prevents metamorphosis to the pupal and adult life stages.  With high JH levels, the 
larva molts into the next larval instar (Klowden 2002). With low JH levels, an increase in 
ecdysone levels initiates a cascade of events resulting in a molt to the pupal stage 
(Borovsky and Van Handel 1979). The presence of additional methoprene in the larval 
mosquito interferes with ecdysone induced gene expression, and prevents midgut 
remodeling during the pupal stage, causing the death of the larvae (Wu et al. 2006). 
The effect of methoprene on imagos has received less attention despite known 
effects of JH on adult physiology.  Methoprene, in combination with fipronil, was 
associated with a significantly lowered fecundity and egg viability in fleas (Franc et al. 
2007). In mosquitoes, an association has been shown between methoprene and 
vitellogenesis (Flanagan and Hagedorn 1977). Following eclosion, JH initiates follicular 
development, until approximately one day after eclosion (Gwadz and Spielman 1973), at 
which time the follicles reach a “resting stage” of about 100 µm in length.  After blood-
feeding, JH levels drop, increasing again after the eggs are laid (Noriega 2004). During 
this period of lowered JH titre, follicles in the resting stage are exposed to ecdysone, 
which causes them to fully develop  (Hagedorn et al. 1979). Furthermore, application of 
JH causes decrease in ecdysteriod levels in adult female mosquitoes following a blood 
meal (Bai et al. 2010).  In one prior study, methoprene applied to adult female Ae. 
aegypti resulted in follicular blockage (Judson and Lumen 1976). In the latter study, 
while an effect on egg laying was described, fecundity was not quantified.  
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The objective of this study was to analyze the effects of methoprene on the 
fecundity and mortality of adult Ae. aegypti, focusing on the impact of differing 
methoprene concentrations across two gonotrophic cycles. I tested for an effect of 
methoprene application on female reproduction and also examined whether application of 
methoprene to males at the same levels affects male survival. 
 
Methods 
Methoprene 
Concentrations of 1%, 0.1% and 0.01% methoprene were made by diluting 
99.97% technical grade methoprene (Central Life Sciences, Dallas, Texas) with acetone. 
The control was acetone alone. 
 
Mosquitoes 
Mosquitoes used in the droplet and spray methoprene application studies were the 
Liverpool strain of Ae. aegypti, obtained from the NIAID/NIH Filariasis Research 
Reagent Resource Center (FR3) in June 2009.  For male competitiveness experiments, 
the strains used were Waco, which is naturally uninfected with the Wolbachia symbiont, 
and WB1, which has been infected with Wolbachia by microinjection (Xi et al. 2005). 
The colonies were maintained as previously described (Gavotte et al. 2009).  In brief, 
seed germination paper (Anchor Paper, Saint Paul, Minnesota) which mosquitoes had 
oviposited on were submerged in 500 ml water and emergent larvae were reared in 
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optimal conditions with the daily addition of food (6.0% liver powder solution).  All 
mosquitoes used in this study were kept at 27ºC and 70% RH, with a 14:10 hour light: 
dark cycle inside an incubator (Model I-36VL, Percival Scientific, Perry, IA).  Cages of 
adults were provided constantly with a 10% sucrose solution.  
 
Droplet Application 
Mosquitoes were aspirated from the maintenance colony 3 d after eclosion using a 
motorized aspirator, and then anesthetized with chloroform for 30 s.  Each mosquito was 
placed ventral side up using soft forceps, and 1 µl of test solution was applied directly to 
the abdomen using an Eppendorf 2 µl micropipette (Hamilton, Reno, NV).  Fifty dosed 
male and female mosquitoes were then moved into each of four cages (one for each 
experimental concentration, as well as one control cage treated with acetone) constructed 
of 2.5 liter wax paper buckets (Solo Cup, Lake Forest, IL) with a sleeve attached to the 
side constructed of medical stockinette (Dynarex, Orangeburg, NY).  Mosquitoes were 
given an hour to recover from the chloroform before cotton soaked in sucrose was 
provided for sugar feeding.   
Three days after dosing, mosquitoes were provided one anesthetized mouse 
(IACUC #00905A2005) to feed on for 15 min.  After feeding, one oviposition cup 
constructed of a piece of seed germination paper placed in a plastic 50 ml cup half full of 
water was set in each cage.  After 1 wk (allowing for the completion of one gonotrophic 
cycle) the oviposition cup was replaced and the mosquitoes were allowed to feed again.  
At this time mortality and numbers of eggs were recorded.  This process was completed 
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for two full gonotrophic cycles (14 d).  Each paper was dried for one week before being 
submerged in 500 ml water with 1ml 6.0% liver powder solution for 24 hours.  After this 
period the numbers of larvae present were counted.  This experiment was repeated three 
times. 
Due to an incubator malfunction, no eggs were observed in one of the control 
samples, so that sample was excluded.  The same malfunction prevented collection of 
larval emergence data for replicate two, and those samples were excluded. 
Spray Application 
Mosquitoes were aspirated from the maintenance colony 3 d after eclosion.  Once 
aspirated, mosquitoes were counted and then, without being anesthetized, placed in a 50 
ml plastic cup covered in bridal veil. Means of 11.2 females (range 10-15) and 14.8 males 
(range 10-25) were removed for each concentration.  Each cup was then placed in an 18.9 
liter garbage bag, where the cup was sprayed twice with a 50 ml fingertip sprayer (The 
Bottle Crew, West Bloomfield, MI) containing the methoprene test solution.  Droplet size 
produced by these sprayers was 0.17±0.04 mm diameter, droplet density 2.5±0.7 droplets 
per mm
2
, determined through the use of water sensitive paper (Teejet, Springfield, IL).  
During application the sprayer was held 10 cm away from the container.  After 
application of the solution, mosquitoes were moved to wax paper cages similar to those 
used in experiment one.  Each cage was provided sucrose soaked cotton to feed on ad 
libitum.   
After 3 d each cage was provided an anesthetized mouse for feeding and an 
oviposition cup, and mortality was recorded.  This process was completed for two full 
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gonotrophic cycles (14 d).  The total number of larvae emerging was assessed as 
described for droplet application experiment, above. This experiment was repeated five 
times. 
Dissections – Ovarial measurements 
Forty female mosquitoes were taken aside from the main colony 3 d after 
eclosion, and 10 were treated with one of the three methoprene solutions and acetone by 
droplet abdominal application as described above.  Females were kept with 10 males for 
3 d before being provided an anesthetized mouse to feed on.  After 48 h, all blood-fed 
female mosquitoes were dissected in order to observe the effects of the solution on their 
ovaries. 
Images were collected of the ovaries using a Leica EZ 4 HD light dissecting 
microscope, and processed using Leica Application Suite 2.0 software.  These images 
were used to calculate average length of the ovaries, as well as average number of 
oocytes.  There was a distinction in shape between treated and untreated ovarioles, and 
this was shown by calculating the circularity of the ovarioles.  Circularity is a value 
between 0 (linear) and 1 (round). 
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Statistics 
Mortality of males and females was assessed using a Cox Proportional Hazards 
Analysis to examine significance of the differences among treatments. Kruskal-Wallis 
nonparametric analysis of variance was used to examine significance of the differences in 
fecundity among experimental treatments (α = 0.05) for fecundity measures (eggs per 
female and number of larvae). Pairwise comparisons were made using the Dunn method. 
Student’s t-test and analysis of variance were performed to determine significance of the 
differences among treatments (α = 0.05) for all values of ovary/oocyte length, circularity, 
and oocyte number. All analyses were performed in JMP v.9 (SAS Institute Inc., Cary, 
NC). 
Results 
Droplet application 
Application of a methoprene solution significantly increased female mortality 
(χ2=53.1; df = 3; P < 0.0001).  Adult female mosquitoes treated with the 1.0% solution 
experienced significantly higher mortality than the other treatments (P < 0.0001).  In 
males, a similar result was observed (χ2 = 44.0; df = 3; P < 0.0001), with a significant 
difference between the 1.0% solution and the other treatments (P < 0.0001; Table 2.1).   
 There were no significant differences in fecundity values between the two 
observed gonotrophic cycles (χ2=0.03; P = 0.86), therefore fecundity values for both 
cycles were consolidated for analysis (Table 2.1).  Direct application of methoprene to 
the abdomens of adult females had a significant effect on fecundity (χ2 = 20.7; df = 3; P = 
0.0001). Control mosquitoes produced significantly more eggs/female than mosquitoes 
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treated with 1.0% (P < 0.001), 0.1% (P < 0.01), and 0.01% (P = 0.04) methoprene 
concentrations.  Surviving mosquitoes treated with the 0.01% and 0.1% methoprene 
concentrations laid significantly more eggs than mosquitoes treated with the 1.0% 
methoprene concentration (P = 0.001). 
Methoprene application had a significant effect on the number of larvae resulting 
from the eggs of surviving treated mosquitoes (χ2 = 12.3; df = 3; P < 0.01). Mosquito 
females treated with the control solution yielded significantly more larvae than all other 
solutions (P = 0.0001). Fecundity values, separated by gonotrophic cycle, can be found in 
Table 2.1. 
Spray application 
 Spray application of methoprene has a significant effect on female mortality (χ2 = 
24.1; df = 3; P < 0.0001). Female mosquitoes treated with 1.0% methoprene spray 
experienced significantly higher mortality than control (P < 0.0001), 0.01% (P < 0.001), 
and 0.1% (P = 0.05) methoprene spray treated mosquitoes. There was also a significantly 
higher mortality noted in the females treated with the 0.1% solution when compared with 
the control spray treatment (P = 0.01). Male mosquitoes also experienced a significant 
difference in mortality (χ2 = 27.0; df = 3; P < 0.0001); those treated with 1.0% 
methoprene spray solution experienced higher mortality than control (P < 0.0001), 0.01% 
(P < 0.0001), and 0.1% (P < 0.001) methoprene spray treated mosquitoes (Table 2.2).  
There were no significant differences in fecundity values between the two 
observed gonotrophic cycles (χ2 = 0.19; df = 1; P = 0.67), therefore fecundity values for 
both cycles were consolidated for analysis. Treatment with a methoprene spray had a 
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significant effect on fecundity (χ2 = 26.0; df = 3; P < 0.0001).  Females treated with the 
Control spray laid significantly more eggs than both the 0.1% methoprene treatment (P = 
0.03) and the 1.0% methoprene treatment (P < 0.0001). Females treated with 0.01% 
methoprene laid significantly more eggs than those treated with 1.0% methoprene 
solution (P < 0.001).   The methoprene spray had a significant effect on the number of 
neonate larvae produced by each treated female mosquito (χ2 =17.1; df = 3; P < 0.001). 
Control females had significantly more offspring resulting from their eggs than both 
0.1% (P < 0.01) and 1.0% (P < 0.01) methoprene solutions. The 0.01% methoprene 
treated females produced significantly more eggs than both the 0.1% (P = 0.02) and 1.0% 
(P < 0.01) methoprene solutions (Figure 2.2). 
Dissections – Ovarial measurements 
Methoprene treatment caused a significant reduction in the length of adult female 
ovaries (t = 2.78; df = 3; P < 0.01). The ovaries of female mosquitoes treated with 1.0% 
methoprene (Figure 2.1D) were significantly smaller than those mosquitoes treated with 
acetone control solution (Figure 2.1A; P < 0.01), 0.01% methoprene (Figure 1B; P = 
0.01) and 0.1% methoprene (Figure 2.1C; P < 0.01).  Methoprene also affected length of 
the adult female oocytes (t = 2.03; df = 3; P < 0.0001). Oocytes of the females treated 
with control or 1.0% solutions were significantly longer or smaller, respectively, than all 
other concentrations (P < 0.0001). The 0.01% and 0.1% solutions did not significantly 
differ from each other (P = 0.28). The highest dosage of methoprene (1.0%) significantly 
increased the number of oocytes within the ovaries of treated females relative to all other 
concentrations (t = 2.78; df = 3; P < 0.001).  Lower levels of methoprene did not affect 
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oocyte number (Table 2.3).  Circularity of the oocytes was significantly increased by all 
rates of treatment with methoprene (t = 2.12; df = 3; P = 0.0001; Table 2.3).   
Discussion 
Under the conditions tested here, all rates of methoprene significantly reduced the 
fecundity of adult female mosquitoes, and the highest rate (1.0%) had a level of acute 
toxicity, which caused increased mortality within 3 d after treatment. Methoprene also 
affected the ovarial development of the female mosquitoes, reducing ovary and oocyte 
length, as well as increasing oocyte circularity. Treatment with methoprene caused the 
oocytes to remain at a small state, similar to their size before bloodfeeding. These 
reduced oocytes were incapable of fully maturing into eggs, and the females were unable 
to produce offspring. The 1.0% methoprene treatment also caused an increase in the 
numbers of oocytes contained within each ovary, as noted previously by Judson and 
Lumen (1976).  In addition, those few eggs that were laid by the treated mosquitoes were 
less likely to hatch. This effect continued through the second gonotrophic cycle of the 
insect, effectively preventing the mosquito from producing offspring.   
It is known that JH performs regulatory functions during vitellogenesis (Borovsky 
1981).  Before blood feeding, after the oocytes have reached a resting stage, JH levels 
drop, shortly before ecdysone is released (Noriega 2004). The results of this study could 
indicate a regression of the ovaries to the period of vitellogenesis, prior to the resting 
stage. Previous studies have noted that the length of oocytes  Ae. aegypti mosquitoes 
which have entered the resting stage averaged 0.11 ± 0.01mm, increasing to 0.31 ± 
0.02mm after bloodfeeding (Briegel et al. 2003).  Ovaries of methoprene treated females 
17 
 
measured are similar in length to those previously recorded in the resting stage, while the 
oocytes of those mosquitoes treated with the control solution were capable of developing 
fully, indicating a regression in the ovary development in treated individuals.  This 
regression explains the reduction in size of the oocytes, as well as the increased number 
of oocytes.  Prior studies have noted this change, but have attributed it to the feeding 
habits of the treated Ae. nigripalpus mosquitoes. Hancock and Foster (2000) noted that 
mosquitoes, when treated with JH, were more likely to seek a blood meal than to feed on 
sugar, and that mosquitoes that consumed low amounts of sugar also exhibited lower 
insemination rates.  This relationship led them to attribute the reduced oocyte 
development with the lack of a sugar meal (Hancock and Foster 2000). In the present 
study, mosquitoes were allowed ample time to mate and sugar feed prior to treatment, 
which would allow time for the ovaries to develop completely to the resting stage. This 
was confirmed by observation. Oocytes of treated females nevertheless regress to a 
smaller size even after the initial sugar meal has occurred.   
For methoprene applications to play a useful role in a sex-separation strategy for 
mass releases, in addition to reducing female fecundity, it is a necessity that male mating 
performance is not affected negatively. Methoprene treatment must be able to inactivate 
the female reproductive systems, while not having a significant effect on male survival.  
The results of this study indicate that there are no significant effects on mortality caused 
by methoprene treatment at all but the heaviest treatment levels.  
To our knowledge, the effect of JH on male mosquito mating performance has not 
previously been investigated. Earlier sexual maturation and enhanced pheromone release 
as a result of topical JH or methoprene application to tephritid fruit flies has been 
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demonstrated (Teal et al. 2000; Pereira et al. 2009; Haq et al. 2010). It is not clear why, if 
it occurred here, a competitive advantage would be limited to Wolbachia-infected males. 
To confirm this mating advantage, further studies should explicitly take the occurrence of 
multiple insemination, male body size and energetic reserves, and male accessory gland 
development into account. 
Due to the targeted effects of methoprene on the female reproductive system, it 
could prove useful in the implementation of Sterile Insect Techniques (SIT). This 
technique aims to release into nature large numbers of sterile male insects to compete 
with naturally occurring males for females, potentially lowering populations of pest 
species (Klassen and Curtis 2005). With current methodology, all males have to be 
separated from the females prior to release.  This is particularly important in species 
where the female insects transmit disease. However, no separation method for 
mosquitoes has proven to be absolute (Alphey 2007). By spraying 0.1% methoprene on 
all of the mosquitoes prior to release, there would be a reduced likelihood that any 
females missed during the sorting process would be capable of establishing a population.  
The results of this study show that the fecundity of these released females can be reduced 
while not reducing the survival or mating competitiveness of the released males. 
Extrapolations to field applications of this technique have to be made with great care due 
to the spatially-restrictive and carefully-controlled laboratory conditions employed. The 
current results support follow-up experiments in greenhouse enclosures, in which 
suppression scenarios using methoprene-treated males can be undertaken and the 
likelihood of accidentally-released females reproducing assessed under more natural 
conditions.  
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The potential of methoprene to impact adult mosquitoes also indicates that there 
may be applications for methoprene in the field of vector control as an air dispersed adult 
treatment.  Methoprene is currently being applied in the field to large water sources, so 
there should be minimal cross contamination between a spray application of methoprene 
targeting adults and the treatment of water sources targeting larvae.  Aerial application of 
methoprene to a terrestrial environment raises concern about non-target effects. 
Currently, aerial methoprene applications occur only in strictly controlled man-made 
environments (Csondes 2004).  This is primarily limited to fields where flooding is used 
to irrigate crops, for example rice and dates.  Under these conditions, the primary targets 
of the aerial treatment are still aquatic dipteran larvae, and effects upon terrestrial insects 
during these treatment conditions have not been noted. Prior studies have focused on the 
effects upon aquatic insects, and have not indicated any acute negative effects on either 
invertebrates or vertebrates (Glare and O’Callaghan 1999).  However, this study does 
indicate a need to assess methoprene effects other than direct mortality effects.  It is 
possible that methoprene could have long term population effects by lowering fecundity 
in other invertebrates.  
Application of this method under controlled conditions in the field could yield 
important knowledge of the effects on other possible targets, as well as illuminating any 
complications. For instance, methoprene readily breaks down in light (Csondes 2004), 
and may not survive long enough in field conditions to be useful, so studies to determine 
the viability of methoprene as an ovicide spread by adult application are needed.  Our 
results indicate that further research in this area is warranted. 
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Table 2.1: Mortality and fecundity measures resulting from droplet application of 
methoprene to the abdomens of Ae. aegypti mosquitoes 
Time Treatment 
% Female 
mortality 
% Male 
mortality 
No. of eggs 
per female 
No. of larvae 
per female 
Week One Control 16.5±9.6 22.5±6.6 4.8±2.3 1.4±2.3 
 0.01% 8.7±5.0 24.7±13.3 1.5±1.07 0.04±0.04 
 0.10% 14.7±16.8 32.0±13.4 0.9±0.2 0.01±0.02 
 1.00% 43.0±34.5 56.5±38.3 0±0 0 
      
Week Two Control 34.0±10.0 44.5±14.1 3.7±3.1 0.6±0.8 
 0.01% 28.7±5.3 39.4±14.0 3.7±2.5 0.02±0.03 
 0.10% 41.4±19.0 46.0±4.4 1.1±0.1 0 
 1.00% 64.0±13.9 69.5±6.2 0±0 0 
 
 
 
 
Table 2.2: Mortality and fecundity measures resulting from Ae. aegypti mosquitoes 
treated with methoprene spray applications 
Time Treatment 
% Female 
mortality 
% Male 
mortality 
No. of eggs 
per female 
No. of larvae 
per female 
3 Days Control 3.7±5.1 6.8±4.0 --- --- 
 0.01% 10.3±15.1 11.9±11.5 --- --- 
 0.1% 22.2±19.6 22.2±14.1 --- --- 
 1.0% 53.0±28.2 62.3±29.5 --- --- 
      
10 Days Control 16.2±9.5 34.9±23.6 34.5±31.5 22.7±14.4 
 0.01% 29.9±7.5 34.8±10.3 34.5±22.9 16.5±16.0 
 0.1% 40.1±13.9 42.5±9.8 3.2±5.3 3.1±3.8 
 1.0% 67.9±11.3 80.8±13.0 0±0 0.0±0.1 
      
17 Days Control 35.0±19.6 54.9±16.4 60.5±30.8 21.6±14.5 
 0.01% 40.5±11.7 51.2±12.5 51.3±31.6 14.3±7.3 
 0.1% 61.0±18.1 56.3±15.3 11.8±13.9 5.0±5.3 
 1.0% 73.4±12.2 86.0±5.5 10±22.4 0.5±1.0 
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Table 2.3: Length of ovaries as well as numbers, circularity, and length of oocytes 
calculated from dissections of Ae. aegypti mosquitoes 
Treatment Ovary length (mm) Oocyte length (mm) No. of oocytes Circularity 
Control 1.76±0.08 0.38±0.02 20.5±0.71 0.71±0.03 
0.01% 1.73±0.28 0.29±0.03 22.5±6.36 0.89±0.03 
0.10% 1.79±0.06 0.28±0.03 22.0±1.41 0.88±0.02 
1.00% 1.01±0.08 0.11±0.02 39.5±2.12 0.89±0.05 
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Figure 2.1: Ae. aegypti ovaries treated with methoprene. Ovaries were removed 48 hours 
post-bloodmeal.  A) Ovary treated with acetone control B) 0.01% methoprene treated 
ovary C) 0.1% methoprene treated ovary D) 1.0% methoprene treated ovary. Scale bar is 
equivalent to 1mm. 
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Chapter 3 
Effects of methoprene on adult Aedes albopictus and Aedes polynesiensis mosquitoes 
Introduction 
Previously, methoprene was applied, both by droplet and spray application, to 
adult Ae. aegypti mosquitoes.  Application of methoprene caused a reduction in the size 
of female oocytes and a significant drop in fecundity.  There were significant effects on 
mortality noted at high concentrations of methoprene, but no significant differences at 
lower treatment levels.  The effect on reproduction was hypothesized to be connected to 
the appearance of the mosquito ovaries that had been arrested in a “resting stage” 
approximately 100 µm in length (Chapter 2).  
The observation in Chapter 2, that methoprene has a greater effect on females 
relative to males, has a potential applied use. If applied to control methods based on mass 
releases of male mosquitoes, pretreatment of the release material with methoprene could 
have relatively little effect on the males while diminishing the potential fecundity any 
unintentionally released females. Examples include SIT strategies in which Wolbachia 
infected male mosquitoes are released for population suppression.  This approach is 
based on Wolbachia-induced cytoplasmic incompatibility and is being developed for 
various mosquito species (Atyame et al., 2011).  
 The purpose of this study was to assess the differences in fecundity and mortality 
measures, if any, in treatment effects of methoprene on other members of the genus 
Aedes.  By analyzing these differences, the authors hope to gain an understanding of the 
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capabilities of methoprene as a method of reducing female mosquito reproductive 
success.  The two species chosen for this study were chosen for specific reasons.  
 Ae. albopictus, the Asian Tiger Mosquito, is an important invasive pest which has 
become prevalent in the United States.  It is a highly anthropophillic day feeding 
mosquito which is competent vector of many human and animal diseases. Ae. albopictus 
is a capable vector for Dengue, West Nile, LaCrosse, and Chikungunya viruses, and also 
Dog Heartworm (Juliano and Lounibos, 2005).  This mosquito has dramatically increased 
in range recently, helped by the international trade of tires, which can contain mosquito 
eggs (Reiter 1998). Studies have illustrated that Ae. albopictus can already be found in 
over 26 countries, and has the potential to become globally cosmopolitan (Benedict et al, 
2007).  Control of Ae. albopictus is difficult, due to the tendency of the species to use 
small, hard to find sources of water.  An aerial application of methoprene has the 
potential to reach adult Ae. albopictus mosquitoes in urban environments that would 
otherwise be difficult to successfully treat with insecticide.  
Ae. polynesiensis, the Polynesian Tiger Mosquito, is an important vector of 
Lymphatic Filariasis in the South Pacific (Nicholas and Scoles, 1997).   Ae. polysiensis 
are diurnal and feeding peaks at dawn and dusk (Russell 2004).  As with other Aedes 
species, vector control is complicated due to the small containers used by Ae. 
polynesiensis (Lardeux et al, 2002). Recent work with this pest has focused on the release 
of incompatible male mosquitoes for population control (Brelsfoard et al, 2008).   
 Pesticide exposure also differs between the species and strains utilized.  Ae. 
aegypti mosquitoes previously analyzed were members of the Liverpool strain, colonized 
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prior to the invention of methoprene (Macdonald 1962).  Consequently, it is possible that  
results received using a long maintained laboratory colony might be different than effects 
on wild populations.  Ae. albopictus used for this study were collected from an existing 
wild population in order to show the applicability of methoprene as a treatment against 
established populations of mosquitoes.  Application of methoprene to Ae. albopictus in 
this study is to illustrate the effects of a methoprene treatment on wild populations of 
mosquitoes.  This will illustrate the practicality of methoprene as a spray treatment under 
field conditions.   
In contrast, mosquitoes in the South Pacific area have had less exposure to insect 
growth regulators.  Since the advent of methoprene in 1972, applications of methoprene 
in the South Pacific region have increased, though not to the levels used in the continental 
US (Russell and Kay 2004).  Ae. polynesiensis used in this study were from a laboratory 
raised colony of potential Wolbachia biopesticide control mosquitoes.  These mosquitoes 
have been raised with a novel infection of Wolbachia bacterium for use in mass release 
and population suppression (Brelsfoard et al, 2007). Also, due to the environmental 
constraints of using pesticides in an island habitat, methoprene is primarily used within 
cities (Wood et al, 2007).  Water treatment does not assist with the control of Ae. 
polynesiensis, due to the number of smaller, natural water sources used as breeding sites 
in island habitats (Rosen et al, 1954).  
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Methods 
Methoprene 
One gram of 99.97% technical grade methoprene was obtained from Central Life 
Sciences (Dallas, Texas) for use during this study.  For this study, 50 mL concentrations 
of 1%, 0.1%, 0.01% and 0.001% methoprene were created by blending technical grade 
methoprene with acetone. The control solution was acetone alone. 
Mosquitoes 
Two species of Aedes mosquitoes were used in this study.  Ae. albopictus 
mosquitoes belonged to the WC strain, which was collected wild in Lexington, Kentucky 
during the summer of 2011 and established as a laboratory colony.  Ae. polynesiensis 
mosquitoes belonged to the CP strain (Brelsfoard et al, 2007).  The colonies were 
maintained as previously described (Chapter 2).  In brief, seed germination paper 
(Anchor Paper, Saint Paul, Minnesota) which mosquitoes had oviposited on were 
submerged in 500 ml water and emergent larvae were reared in optimal conditions with 
the daily addition of food (6.0% liver powder solution).  All mosquitoes used in this 
study were kept at 27ºC and 70% RH, with a 14:10 hour light: dark cycle inside an 
incubator (Model I-36VL, Percival Scientific, Perry, IA).  Cages of adults were provided 
constantly with a 10% sucrose solution. 
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Droplet Application 
Mosquitoes were aspirated from the maintenance colony three days after pupation 
using a motorized aspirator, and then anesthetized with chloroform for 30 seconds.  Each 
mosquito was placed ventral side up using soft forceps, and 0.5 µL of test solution was 
applied directly to the abdomen using an Eppendorf 2 µL micropipette (Hamilton; Reno, 
Nevada).  Twenty dosed male and female mosquitoes were then moved into each of five 
cages (one for each experimental concentration, as well as one control cage treated with 
acetone) constructed of 83oz wax paper buckets (Solo Cup Company; Lake Forest 
Illinois) with a sleeve attached to the side constructed of medical stockinette (Dynarex; 
Orangeburg, New York).  Mosquitoes were given an hour to recover from the chloroform 
before sucrose wicks were provided.   
Three days after dosing, mosquitoes were provided one anesthetized mouse 
(IACUC #00905A2005) to feed on for 15 minutes.  After feeding, one oviposition cup 
constructed of a piece of seed germination paper (Anchor paper company) placed in a cup 
half full of water was set in each cage.  After one week (allowing for the completion of 
one gonotrophic cycle) the oviposition cup was replaced and the mosquitoes were 
allowed to feed again.  At this time mortality and numbers of eggs was recorded.  This 
process was completed for two full gonotrophic cycles (14 d).  Each paper was dried for 
one week before being submerged in 500 mL water with 1mL 6.0% liver powder solution 
for 24 hours.  After this period the numbers of larvae present were counted in order to 
assess the number of larvae emerging per adult female mosquito.  This experiment was 
repeated three times for Ae. polynesiensis. This experiment was not performed on Ae. 
albopictus, as the applications of methoprene consumed a significant amount of time. 
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Spray Application 
Mosquitoes were aspirated from the maintenance colony three days after eclosion.  
Once aspirated, mosquitoes were counted and then, without being anesthetized, placed in 
a small plastic cup covered in bridal veil. Approximately 10 females and 10 males were 
removed for each concentration.  Each cup was then placed in a 18.9 L garbage bag to 
prevent the spread of methoprene from the testing area, where the cup was sprayed twice 
with a 50 ml fingertip sprayer (The Bottle Crew; West Bloomfield, Michigan) containing 
the methoprene test solution.  Droplet size produced by these sprayers was 0.17±0.04mm, 
droplet density 2.5±0.7 droplets per mm
2
, determined through the use of water sensitive 
paper (Teejet; Springfield, Illinois).  During application the sprayer was held 10 cm away 
from the container.  After application of the solution, mosquitoes were moved to wax 
paper cages similar to those used in experiment one.  Each cage was provided a sucrose 
soaked wick to feed on ad libitum.   
After three days each cage was provided an anesthetized mouse for feeding and 
an oviposition cup, and mortality was recorded.  This process was completed for two full 
gonotrophic cycles (14 d).  The total number of larvae emerging was assessed as 
described for the droplet application, above. This experiment was repeated five times. 
Dissections – Ovarial measurements 
Forty female mosquitoes were separated from the main colony three days after 
eclosion, and 10 were treated with one of the four experimental methoprene solutions by 
direct abdominal application similar to experiment one.  Females were kept with 10 
males for three days before being provided an anesthetized mouse to feed on.  All 
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mosquitoes that did not feed were then removed.  After 48 hours all blood-fed female 
mosquitoes were dissected in order to observe the effects of the solution on their ovaries. 
Images were collected of the ovaries using a Leica EZ 4 HD light dissecting 
microscope, and processed using Leica Application Suite 2.0 software.  These images 
were used to calculate average length of the ovaries, as well as average number of 
oocytes.  There was a distinction in shape between treated and untreated ovarioles, and 
this was shown by calculating the circularity of the ovarioles.  Circularity is a value 
between 0 and 1 which indicates how close a particle is to perfectly round.  When this 
value is 1, the particle is perfectly round. 
Results 
Droplet application 
Application of a methoprene solution had a significant effect on Ae. polynesiensis 
female mortality (χ2=111.8; df = 3; P < 0.0001).  Adult female mosquitoes treated with 
the 1.0% solution experienced significantly higher mortality than the other treatments (P 
< 0.0001; Table 3.1).  Also, female mosquitoes treated with the control solution 
experienced a significantly lower mortality than all other treatments (P < 0.0001).  In 
males, a similar result was observed (χ2 = 57.10; df = 3; P < 0.0001), with significantly 
higher mortality between the 1.0% solution and the other treatments (P < 0.0001; Table 
3.1), and a significantly lower mortality between the control and all other treatments (P < 
0.0001; Table 3.1).   
 There were no significant differences in fecundity values between the two 
observed gonotrophic cycles (χ2= 0.08; P = 0.8), therefore fecundity values for both 
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cycles were combined for analysis (Table 3.1).  Direct application of methoprene to the 
abdomens of adult females had a significant effect on fecundity (χ2 = 16.4; df = 3; P = 
0.001). Control mosquitoes produced significantly more eggs/female than mosquitoes 
treated with 1.0% (P = 0.003) and 0.1% (P = 0.003), but not significantly more than those 
mosquitoes treated with 0.01% (P = 0.06) methoprene concentrations.  There were no 
other significant relationships in egg production (Table 3.1). 
Methoprene application had a significant effect on the number of larvae resulting 
from the eggs of treated mosquitoes (χ2 = 10.2; df = 3; P = 0.02). Mosquito females 
treated with the control solution yielded significantly more larvae than than mosquitoes 
treated with 1.0% (P = 0.03) and 0.1% (P = 0.03), but not significantly more than those 
mosquitoes treated with 0.01% (P = 0.13) methoprene concentrations.  Fecundity values, 
separated by gonotrophic cycle, can be found in Table 3.1. 
Spray application 
Aedes polynesiensis 
 Spray application of methoprene has a significant effect on Ae. polynesiensis 
female mortality (χ2 = 39.4; df = 3; P <0.0001). Female mosquitoes treated with 0.1% 
methoprene spray experienced significantly higher mortality than control (P < 0.0001), 
0.001% (P < 0.0001), but was not significantly higher than those mosquitoes treated with 
0.01% (P = 0.5) methoprene spray. There was also a significantly higher mortality noted 
in the females treated with the 0.01% solution when compared with the control spray 
treatment (P < 0.0001) and the 0.001% solution (P = 0.0005). Male Ae. polynesiensis 
mosquitoes also experienced a significant difference in mortality (χ2 = 20.77; df = 3; P = 
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0.0001).  Male mosquitoes treated with 0.1% methoprene spray solution experienced 
significantly higher mortality than control (P < 0.0001), 0.001% (P < 0.001), and 0.01% 
(P = 0.02) methoprene spray treated mosquitoes. Male mosquitoes treated with 0.01% 
methoprene spray also experienced significantly higher mortality than mosquitoes treated 
with control spray (P =0.02; Table 3.2).  
There were no significant differences in fecundity values between the two 
observed gonotrophic cycles for Ae. polynesiensis (χ2 = 0.2; P = 0.7), therefore fecundity 
values for both cycles were consolidated for analysis. Treatment with a methoprene spray 
had a significant effect on fecundity (χ2 = 24.63; df = 3; P < 0.0001).  Females treated 
with the Control spray laid significantly more eggs than both the 0.01% methoprene 
treatment (P = 0.003) and the 0.1% methoprene treatment (P < 0.001). Females treated 
with 0.001% methoprene laid significantly more eggs than those treated with 0.01% 
methoprene solution (P = 0.0019) and those treated with the 0.1% methoprene solution(P 
= 0.0006).  Females treated with 0.01% methoprene laid significantly more eggs than 
those treated with 0.1% methoprene solution (P = 0.0025).  The methoprene spray had a 
significant effect on the number of first instar larvae produced by each treated female 
mosquito (χ2 =22.30; df= 3; P < 0.0001). Control females had significantly more 
offspring resulting from their eggs than both 0.01% (P = 0.005) and 0.1% (P = 0.002) 
methoprene solutions. The 0.001% methoprene treated females were capable of laying 
significantly more eggs than both the 0.01% (P = 0.001) and 0.1% (P = 0.004) 
methoprene solutions. Specific values can be found in Table 3.2. 
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Aedes albopictus 
 Spray application of methoprene has a significant effect on Ae. albopictus female 
mortality (χ2 = 80.2; df = 3; P < 0.0001). Female mosquitoes treated with 1.0% 
methoprene spray experienced significantly higher mortality than control (P < 0.0001), 
0.01% (P < 0.0001), and 0.1% (P <0.0001) methoprene spray. There was also a 
significantly higher mortality noted in the females treated with the 0.1% solution when 
compared with the control spray treatment (P = 0.007) and the 0.01% solution (P = 0.03). 
Male Ae. albopictus mosquitoes also experienced a significant difference in mortality (χ2 
= 86.9; df = 3; P < 0.0001).  Male mosquitoes treated with 1.0% methoprene spray 
solution experienced significantly higher mortality than control (P < 0.0001), 0.001% (P 
< 0.0001), and 0.01% (P < 0.0001) methoprene spray treated mosquitoes. No other 
significant mortality effects were noted (Table 3.3).  
There were no significant differences in fecundity values between the two 
observed gonotrophic cycles for Ae. albopictus (χ2 = 2.1; P = 0.2), therefore fecundity 
values for both cycles were consolidated for analysis. Treatment with a methoprene spray 
had a significant effect on fecundity (χ2 = 9.0; df = 3; P = 0.04).  Females treated with the 
1.0% methoprene spray laid significantly fewer eggs than the control (P = 0.02), 0.01% 
(P = 0.04), and 0.1% (P = 0.04) methoprene treatments (Table 3.3).  The methoprene 
spray had a significant effect on the number of first instar larvae produced by each treated 
female mosquito (χ2 = 18.9; df= 3; P < 0.001). Control females had significantly more 
offspring resulting from their eggs than 0.01% (P = 0.04), 0.1% (P = 0.008), and 1.0% (P 
= 0.003) methoprene solutions. The 1.0% methoprene treated females were capable of 
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laying significantly less eggs than both the 0.01% (P = 0.003) and 0.1% (P = 0.003) 
methoprene solutions. Specific values can be found in Table 3.3. 
Dissections- Ovarial measurements 
Aedes polynesiensis 
Methoprene treatment has no significant effect on the length of adult female 
ovaries (t = 2.78). The length of the adult female oocytes were significantly affected by 
methoprene treatment (t = 2.03). The oocytes of female mosquitoes treated with the 
control solution were significantly larger than those treated with the 0.01% (P= 0.02) and 
0.1% (0.19±0.10mm; P< 0.0001) solutions, however was not significantly larger than 
oocytes of mosquitoes treated with the 0.001% solution (P= 0.16).  Oocytes of 
mosquitoes treated with 0.1% methoprene solution were significantly smaller than 0.01% 
(P= 0.003) and 0.001% (P= 0.0001) treated mosquitoes.  Methoprene treatment had a 
significant effect on the numbers of oocytes contained within the ovaries (t = 2.78).  
There were significantly more oocytes found in those mosquitoes that have been treated 
with 0.1% methoprene when compared with control (P = 0.04) and 0.001% (P = 0.02) 
methoprene solutions.  There were no more significant oocyte number relationships. 
Circularity was also significantly affected by treatment with methoprene (t = 2.12).  The 
oocytes of the 0.1% methoprene treated mosquitoes were significantly higher in 
circularity than those mosquitoes treated with Control (P< 0.0001), 0.001% (P = 0.03), 
and 0.01% (P = 0.0002) methoprene solutions.  Mosquitoes treated with 0.001% 
methoprene had oocytes which were significantly higher in circularity then 0.01% (P= 
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0.03) and control (P= 0.005) solutions.  Exact values are shown in Table 3.4 and images 
of the dissected ovaries can be observed in Figure 3.1.  
Aedes albopictus 
Methoprene treatment has no significant effect on the length of adult female 
ovaries (t = 2.78). The length of the adult female oocytes were significantly affected by 
methoprene treatment (t = 2.03). The oocytes of female mosquitoes treated with 1.0% 
methoprene solution were significantly smaller than Control (P= 0.0001), 0.01% (P= 
0.001), and 0.1% (P< 0.0001) methoprene solutions.  Methoprene treatment also had a 
significant effect on the numbers of oocytes contained within the ovaries (t = 2.78).  
There were significantly more oocytes found in those mosquitoes treated with the control 
solution than those treated with 0.1% (P= 0.04) and 1% (P= 0.03) methoprene solutions, 
and no significant difference with the 0.01% (P= 0.62) treatment.  Mosquitoes treated 
with 1% methoprene had significantly less oocytes than those treated with Control (P= 
0.03) and 0.01% (P= 0.05) methoprene solutions, and no significant difference from the 
0.1% methoprene solution (P= 0.7).  Circularity was also significantly affected by 
treatment with methoprene (t = 2.12).  The oocytes of the mosquitoes treated with 1.0% 
methoprene solution were significantly higher in circularity than those mosquitoes treated 
with 0.1% (P = 0.03) methoprene solution.  There were no other significant relationships.  
Exact values are shown in Table 3.5 and images of the dissected ovaries can be observed 
in Figure 3.2. 
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Discussion 
The results indicated by this study are similar to those results received previously 
with Ae. aegypti.  Application of methoprene caused the oocytes of female mosquitoes to 
develop poorly, and lowered the fecundity of treated mosquitoes.  Mortality was also 
significantly affected.  Higher concentrations of methoprene caused significant mortality 
in both species tested.  However, there were also marked differences.  
In Ae. polynesiensis, there appeared to be a much lower level of methoprene 
needed in order to achieve acute toxicity.   Mosquitoes treated with 1.0% methoprene did 
not survive long enough for fecundity to be appraised.  100% mortality was reached 
within 24 hours after treatment, too soon for any ovarial development to be determined 
visually.  Instead all treatments were reduced by a factor of ten, allowing observation of 
methoprene effects on ovarial development without reaching significant levels of acute 
mortality.  In both the droplet and spray treatments mortality was higher in comparison to 
previous work with Ae. aegypti and currently with Ae. albopictus.  This can likely be 
attributed to the weakness of the species as a whole.  Mosquitoes treated with the control 
spray still experienced heavy mortality and a reduced fecundity in comparison with the 
Ae. albopictus and Ae. polynesiensis.  Treatment of the mosquitoes using a 0.1% 
methoprene solution was shown to be able to completely remove the ability of the 
mosquito to produce offspring, and produce results similar to those found with Ae. 
aegypti females treated with 1.0% methoprene solution. 
Ae. albopictus mosquitoes seemed to be able to tolerate methoprene treatment 
more easily then Ae. polynesiensis and Ae. aegypti.  At lower levels of methoprene 
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treatment, it does not seem that methoprene had any significant effect on adult mosquito 
health.  There did appear to be a level of acute toxicity associated with 1.0% methoprene 
treatment.  This treatment caused massive level of mortality and appeared to be the only 
level of treatment which significantly affects the numbers of eggs produced.  While 
methoprene treatment of Ae. albopictus did not have a significant effect on egg 
production, it did greatly reduce the amount of neonate larvae which resulted from those 
eggs. Treatment of the mosquito with any level of methoprene causes a significant 
reduction in larval number. Ovarial dissections of the mosquitoes show a potential 
explanation. 
Not all members of the genus have the same reproductive biology.  Ae. albopictus 
and Ae. polynesiensis mosquitoes have a 24 hour longer oocyte development time then 
Ae. aegypti (Personal observations).  In these mosquitoes dissections had to take place 72 
hours post bloodfeeding to observe the same state of ovarial development which was 
visible in Ae. aegypti after 48 hours (Brabant, unpublished findings).  In these mosquitoes 
there appears to be a secondary effect of methoprene exposure.  It was previously noted 
that exposure to methoprene caused reduction in the size of the ovaries, and an increase 
in circularity of the oocytes.  While this effect is present in Ae. polynesiensis, it is not as 
dramatic an effect as in Ae. aegypti.  What is readily visible is a “white fog” rising off the 
individual oocytes which was not previously noted in Ae. aegypti.  This fog appears to be 
the yolk of the oocytes being released into the dissecting solution. This effect is more 
pronounced with higher levels of methoprene.  This could hypothetically represent the 
weakening of the chorion of the developing insect oocyte.  This weakened shell would be 
less likely to hold in nutrients, and would be not be able to support any eggs which were 
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capable of being laid.  In Ae. albopictus this effect is more pronounced.  There is no 
reduction in the size of the oocytes, but there is a cloud rising from the edge of each 
developing egg.  This cloud is the yolk of the oocytes being released, and increases in 
presence for each level of methoprene exposure.  
While the physiological responses within these two mosquito species differ, the 
phenotypic response is the same.  Methoprene causes a significant effect on the female 
mosquito to produce offspring.  This shows that methoprene treatment could be a viable 
method for controlled release of mosquitoes in sterile male release scenarios.  Treatment 
with methoprene prior to release can lower female fecundity to negligible levels, while 
not effecting male mortality.  Future studies can be performed to determine if methoprene 
has any further effects on male virility or reproductive development. 
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Table 3.1: Mortality and fecundity measures involving droplet application of methoprene 
to the abdomen of Ae. polynesiensis 
Time Treatment 
% Female 
mortality 
% Male 
mortality 
No. of eggs 
per female 
No. of 
larvae per 
female 
3 Days Control 18.5±7.5 33.5±3.0 --- --- 
 0.01% 28.5±15.5 68.5±12.5 --- --- 
 0.10% 46.5±16.0 78.5±16.0 --- --- 
 1.00% 96.5±6.0 100.0±0.0 --- --- 
      
10 Days 
 
Control 45.0±15.0 73.5±7.5 --- --- 
0.01% 63.5±29.5 91.5±6.0 --- --- 
 0.10% 78.5±20.0 96.5±3.0 --- --- 
 1.00% 100.0±0.0 100.0±0.0 --- --- 
      
17 Days 
 
Control 65.0±20.0 86.5±10.5 20.4±15.8 9.6±3.9 
0.01% 93.5±7.5 98.5±3.0 12.4±5.1 2.2±5.4 
 0.10% 90.0±10.0 98.5±3.0 0.0±0.0 0.0±0.0 
 1.00% 100.0±0.0 100.0±0.0 0.0±0.0 0.0±0.0 
 
 
Table 3.2: Mortality and fecundity measures involving spray application of 
methoprene to Ae. polynesiensis   
Time Treatment 
% Female 
mortality 
% Male 
mortality 
No. of eggs 
per female 
No. of larvae 
per female 
3 Days Control 17.8±13.2 28.5±17.8 --- --- 
 0.001% 16.1±14.5 33.0±11.5 --- --- 
 0.01% 12.7±9.8 17.2±8.4 --- --- 
 0.1% 45.3±36.7 67.6±34.0 --- --- 
      
10 Days Control 41.0±9.2 56.1±27.0 --- --- 
 0.001% 43.7±25.5 61.0±5.9 --- --- 
 0.01% 60.3±26.6 66.1±14.9 --- --- 
 0.1% 76.7±24.6 81.3±28.4 --- --- 
      
17 Days Control 56.3±13.3 70.8±23.5 27.8±18.2 19.4±14.6 
 0.001% 62.0±14.0 81.1±16.0 19.7±18.5 9.5±11.4 
 0.01% 85.4±13.9 90.7±8.1 3.2±2.8 0.5±0.9 
 0.1% 84.2±18.1 89.7±14.2 0.04±0.1 0.5±1.0 
 
 
39 
 
Table 3.3: Mortality and fecundity measures involving spray application of 
methoprene Ae. albopictus 
Time Treatment 
% Female 
mortality 
% Male 
mortality 
No. of eggs 
per female 
No. of larvae 
per female 
3 Days Control 0±0.0 3.0±5.3 --- --- 
 0.01% 20.2±29.0 21.9±13.0 --- --- 
 0.1% 22.0±6.6 34.6±18.6 --- --- 
 1.0% 85.3±15.4 98.2±3.0 --- --- 
      
10 Days Control 21.2±18.9 71.6±10.6 --- --- 
 0.01% 22.5±27.6 55.6±10.6 --- --- 
 0.1% 40.2±19.5 74.8±16.3 --- --- 
 1.0% 90.4±8.4 98.2±3.0 --- --- 
      
17 Days Control 24.2±22.3 90.4±4.4 37.4±21.4 29.9±17.9 
 0.01% 30.0±31.9 76.3±6.1 28.2±16.0 11.6±7.9 
 0.1% 46.3±22.3 76.7±16.2 19.7±14.4 4.4±7.3 
 1.0% 95.2±4.2 100.0±0.0 8.6±17.2 0.0±0.0 
 
Table 3.4: Length of ovaries as well as numbers, circularity, and length of oocytes 
calculated from dissections performed on Ae. polynesiensis 
Treatment 
Ovary Length 
(mm) 
Oocyte Length 
(mm) 
No. of 
oocytes 
Circularity 
Control 1.45±0.37 0.36±0.04 27.0±8.4 0.62±0.05 
0.001% 1.25±0.35 0.31±0.06 17.5±10.6 0.76±0.04 
0.01% 1.93±0.21 0.28±0.06 41.5±5.0 0.67±0.09 
0.1% 1.84±0.46 0.19±0.10 59.0±17.0 0.85±0.02 
 
Table 3.5: Length of ovaries as well as numbers, circularity, and length of oocytes 
calculated from dissections performed on Ae. albopictus 
Treatment 
Ovary Length 
(mm) 
Oocyte Length 
(mm) 
No. of 
oocytes 
Circularity 
Control 2.33±0.14 0.41±0.02 46.5±2.12 0.70±0.05 
0.01% 1.96±0.07 0.40±0.02 44.5±0.71 0.69±0.03 
0.1% 1.92±0.25 0.41±0.02 35.5±0.71 0.65±0.03 
1.0% 1.73±0.46 0.36±0.03 34.0±7.07 0.72±0.04 
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Figure 3.1:  Ae. polynnesiensis ovaries treated with methoprene.  Ovaries were removed 
72 hours post-bloodmeal. A) Ovary treated with acetone control B) 0.001% methoprene 
treated ovary C) 0.01% methoprene treated ovary D) 0.1% methoprene treated ovary. 
Scale bar is equivalent to 1mm. 
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Figure 3.2:  Ae. albopictus ovaries treated with methoprene. Ovaries were removed 72 
hours post-bloodmeal. A) Ovary treated with acetone control B) 0.01% methoprene 
treated ovary C) 0.1% methoprene treated ovary D) 1.0% methoprene treated ovary. 
Scale bar is equivalent to 1mm. 
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Chapter 4 
Effects of Altosid® on female and male Aedes mosquitoes 
Introduction 
  Prior research has shown that methoprene treatment has a significant effect on 
larval mortality (Norland and DeWitt 1975).  In prior chapters, treatment with 1% 
methoprene causes an immediate drop off in survivorship of mosquitoes, killing many 
within 3 d after treatment. This acute mortality was found in both male and female 
mosquitoes. In order for methoprene treatment to be used with the Wolbachia bio-
pesticide approach, male mortality must be reduced to a minimum. Therefore a less 
severe method of application is required, where fecundity effects remain significant, 
while mortality effects are minimized. 
Altosid® is a commercially available pesticide which functions as an insect 
growth regulator.  It contains a proprietary blend of chemicals, with the active ingredient 
methoprene, which functions by mimicking Juvenile Hormone (JH) as previously 
described in chapter two.  This pesticide is often applied to man-made water sources to 
control nematoceran Diptera, and vector control districts will often use Altosid® to 
control mosquito larvae (Boxmeyer et al. 1997).  Altosid® is formulated for water 
application, and is not known to function against adult mosquitoes (Csondes 2004). The 
commercial formulation of Altosid® contains 5.0% methoprene by volume, which is 
blended with other constituents to enhance dissolution of the pesticide in water. These 
chemicals are inert, and are not known to affect insect populations in any way (Norland 
and DeWitt 1975).  As a commercially available insecticide, Altosid® is more easily 
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obtained than technical grade methoprene, and easily blends with water for simple 
dilutions.   
For these reasons, Altosid® was chosen for assessment as a simple methoprene 
application.  The purpose of this study was to assess the ability of Altosid® to reduce the 
fecundity of adult female mosquitoes while minimizing effects on male mosquitoes, and 
to compare the mortality effects of Altosid® on three different species of mosquitoes 
within the same genus.  This information would prove useful for those working to control 
mosquitoes in the field, in addition to laboratory settings.  For example, Altosid® could 
be shipped easily across the ocean to a laboratory preparing to mass release Wolbachia 
infected males, and once there, could be blended with water and applied to mosquitoes 
that have been isolated prior to release.  Ideally, this application would reduce or 
eliminate the fecundity of any female mosquitoes that were not removed during the 
sorting process, and make it safe to release the males. 
Methods 
Mosquitoes 
Three species of mosquitoes were used in this study.  Ae. aegypti used in this 
study were the Liverpool strain, obtained from the NIAID/NIH Filariasis Research 
Reagent Resource Center (FR3) in June 2009. Ae. albopictus mosquitoes belonged to the 
WC strain, which was collected wild in Lexington, Kentucky during the summer of 2011 
and established as a laboratory colony.  Ae. polynesiensis mosquitoes belonged to the CP 
strain (Brelsfoard et al, 2007).  The colonies were maintained as previously described in 
chapter two.  In brief, seed germination paper (Anchor Paper, Saint Paul, MN) which 
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mosquitoes had oviposited on were submerged in 500 ml water, and emergent larvae 
were reared in optimal conditions with the daily addition of food (6.0% liver powder 
solution).  All mosquitoes used in this study were kept at 27ºC and 70% RH, with a 14:10 
hour light: dark cycle inside an incubator (Model I-36VL, Percival Scientific, Perry, IA).  
Cages of adults were provided constantly with a 10% sucrose solution.  
Spray Application 
Mosquitoes were aspirated from the maintenance colony three days after eclosion.  
Once aspirated, mosquitoes were counted and then transferred to a small plastic cup 
covered in bridal veil. Approximately 10 females and 10 males were used for each 
concentration.  Each cup of mosquitoes were then sprayed with two pumps of a 50 ml 
fingertip sprayer (The Bottle Crew, West Bloomfield, MI) containing the methoprene test 
solution.  Droplet size produced by these sprayers was 0.17±0.04mm, droplet density 
2.5±0.7 droplets per mm
2
, determined through the use of water sensitive paper (Teejet, 
Springfield, IL).  During application the sprayer was held 10 cm away from the container.  
After application of the solution, mosquitoes were moved to cages similar to those 
described in Chapter 1.  Each cage of mosquitoes was provided a sucrose soaked wick to 
feed on ad libitum.   
Three days after dosing, mosquitoes were provided one anesthetized mouse 
(IACUC #00905A2005) to feed on for 15 min.  After feeding, one oviposition cup 
constructed of a piece of seed germination paper placed in a plastic 50 ml cup half full of 
water was set in each cage.  After 1 wk (allowing for the completion of one gonotrophic 
cycle) the oviposition cup was replaced and the mosquitoes were allowed to bloodfeed 
again.  At this time mortality and numbers of eggs were recorded.  This process was 
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completed for two full gonotrophic cycles (14 d).  Each paper was dried for one week 
before being submerged in 500 ml water with 1ml 6.0% liver powder solution for 24 
hours.  After this period the numbers of larvae present were counted.  This experiment 
was replicated five times for each species. 
Treatments 
Aedes aegypti 
 Mosquitoes were treated with 10% Altosid® diluted in water and 1% methoprene 
diluted in acetone.  The 10% Altosid® solution equates to a 0.5% methoprene 
application, half as concentrated as the highest methoprene concentration used in prior 
experiments (Chapters 2 and 3). Control solutions were water and acetone control 
solutions.  The inclusion of a methoprene treatment provided a baseline of comparison 
between this experiment and earlier work (Chapter 2). 
Aedes polynesiensis 
Mosquitoes were treated with 10%, 1.0%, and 0.1% Altosid® solutions, plus a 
water control. These treatments equate to 0.5%, 0.05%, and 0.005% of the active 
ingredient, methoprene.  Ae. polynesiensis has been shown to be less capable of 
withstanding methoprene treatment (Chapter 3), therefore a range of treatments was used 
similar to previous work. 
Aedes albopictus 
 Mosquitoes were treated with 10% Altosid® and water control solutions, in order 
to assess the effects of commercial grade methoprene on wild type mosquitoes. 
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Concentrations of Altosid® were made by diluting commercial grade Altosid® or 
99.97% technical grade methoprene (Central Life Sciences, Dallas, TX) with water or 
acetone, respectively. Altosid® is 5% methoprene by volume.  The control was water 
alone. 
Statistics 
Mortality of males and females was assessed using a Cox Proportional Hazards 
Analysis to examine for significant differences among treatments.  Comparison between 
species was calculated by first correcting mortality using Henderson-Tilton’s calculation 
(Henderson and Tilton 1955), performing arc sine square root transformation on the 
resulting proportions, and then performing an analysis of variance. Kruskal-Wallis 
nonparametric analysis of variance was used to examine for significant differences in 
fecundity among experimental treatments (α = 0.05) for fecundity measures (eggs per 
female and number of larvae). Pairwise comparisons were made using the Dunn method.  
All analyses were performed in JMP v.9 (SAS Institute Inc., Cary, NC). 
 
Results 
Aedes aegypti 
 Spray application of methoprene has a significant effect on female mortality (χ2 = 
37.4; P < 0.0001; Table 4.1). Female mosquitoes treated with 1.0% methoprene spray 
experienced significantly higher mortality than control or 10% Altosid® treatment sprays 
(P < 0.0001). Altosid® treatment caused significantly higher mortality than acetone 
control (P = 0.001), but not the water control (P = 0.3).  Male mosquitoes also 
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experienced a significant difference in mortality (χ2 = 10.0; P = 0.02); those treated with 
1.0% methoprene spray solution experienced higher mortality than both water and 
acetone controls (P = 0.005), and 10% Altosid® treatment (P = 0.02). There were no 
significant differences between the controls. 
There were no significant differences in fecundity values between the two 
observed gonotrophic cycles (χ2 = 0.01; P = 0.93), therefore fecundity values for both 
cycles were consolidated for analysis. Treatment with a methoprene spray had a 
significant effect on fecundity (χ2 = 18.5; P < 0.001).  Females treated with the acetone 
control spray laid significantly more eggs than both the 1.0% methoprene (P = 0.002) and 
the 10% Altosid® treatment (P < 0.001). Females treated with the water control spray 
laid significantly more eggs than those treated with the 1.0% methoprene solution (P = 
0.01) and the 10% Altosid® treatment (P = 0.004).   The methoprene spray had a 
significant effect on the number of neonate larvae produced by each treated female 
mosquito (χ2 =17.1; P < 0.001). Acetone control females had significantly more offspring 
resulting from their eggs than both 1.0% methoprene (P < 0.001) and 10% Altosid® (P = 
0.0001) treatments. The water control treated females produced significantly more eggs 
than both the 1.0% methoprene (P = 0.03) and 10% Altosid® (P < 0.01) solutions (Table 
4.1). 
Aedes polynesiensis 
 Spray application of Altosid® has a significant effect on female mortality (χ2 = 
8.4; P = 0.04). Female mosquitoes treated with 10% Altosid® spray experienced 
significantly higher mortality than control (P= 0.02), 0.1% Altosid® (P= 0.01), and 1.0% 
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Altosid® (P = 0.02) treatment sprays.  There were no significant differences between the 
control and the lower treatment levels. Male mosquito mortality was not significantly 
affected by Altosid® application (χ2 = 2.0; P = 0.5; Table 4.2). 
There were no significant differences in fecundity values between the two 
observed gonotrophic cycles (χ2 = 0.0009; P = 1.0), therefore fecundity values for both 
cycles were consolidated for analysis. Treatment with a methoprene spray had a 
significant effect on fecundity (χ2 = 16.6; P < 0.001).  Females treated with the water 
control spray laid significantly more eggs than the 0.1% Altosid® treatment (P = 0.05), 
1.0% Altosid® (P < 0.0001), and 10% Altosid® (P < 0.0001) treated mosquitoes. 
Females treated with 0.1% Altosid® laid significantly more eggs than those treated with 
the 1.0% Altosid® solution (P = 0.005) and the 10% Altosid® treatment (P = 0.004).   
The methoprene spray had a significant effect on the number of neonate larvae produced 
by each treated female mosquito (χ2 =18.0; P < 0.001). Water control females had 
significantly more offspring resulting from their eggs than both 1.0% Altosid® (P = 
0.002) and 10% Altosid® (P = 0.002) treatments (Table 4.2).  
Aedes albopictus 
 Spray application of Altosid® did not significantly affect female mortality (χ2 = 
0.1; P = 0.7.  Male mosquitoes also did not experience significant mortality from 
Altosid® treatment (χ2 = 0.09; P = 0.8; Table 4.3).    
There were no significant differences in fecundity values between the two 
observed gonotrophic cycles (χ2 = 0.01; P = 0.92), therefore fecundity values for both 
cycles were consolidated for analysis. Treatment with a methoprene spray had a 
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significant effect on fecundity (χ2 = 6.4; P = 0.01).  Females treated with the water control 
spray laid significantly more eggs than the 10% Altosid® treatment (P = 0.01). The 
methoprene spray had a significant effect on the number of neonate larvae produced by 
each treated female mosquito (χ2 = 9.3; P = 0.002). Acetone control females had 
significantly more offspring resulting from their eggs than those treated with 10% 
Altosid® (P = 0.003; Table 4.3). 
Comparison of species 
 There were no significant differences in mortality found between the three species 
observed in this study for males (P = 0.63; Figure 4.1B) or females (P = 0.75; Figure 
4.1A). 
Discussion 
 The results of this study indicate that commercial grade methoprene is capable of 
reducing the fecundity of adult female mosquitoes, similar to prior work with technical 
grade methoprene.  Mosquitoes experienced an acute toxic effect from high levels of 
methoprene dosage, causing significant mortality within 3 d post bloodmeal (Chapter 2).  
When treated with Altosid®, there was a less dramatic effect on mosquito mortality than 
with technical grade methoprene, shown by the higher number of mosquitoes capable of 
surviving until the second gonotrophic cycle (17 d) than previously noted (Chapter 3).  
Female Ae. aegypti mosquitoes experienced significantly higher mortality when 
sprayed with water than acetone control solutions.  Mosquitoes treated with water are 
prevented from flying for a period after treatment, until their wings become dry (Personal 
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observations).  The differences found could have been due to the time it takes the water 
to evaporate from the wings of the mosquitoes being longer than acetone.  
Ae. polynesiensis and Ae. albopictus males were not significantly affected by the 
application of Altosid®, indicating that Altosid® treatment has a less severe effect on the 
males than technical grade methoprene.  Female mosquitoes still suffer from acute 
mortality, though this mortality was not as severe as previously noted (Chapter 2 and 3).  
 The differences between species in both fecundity and mortality measures found 
in this study may have been due to the varying role of JH in treated mosquitoes. In female 
mosquitoes, JH determines the early development of the mosquito ovaries during 
vitellogenesis (Raikhel 2002). Vitellogenisis immediately precedes the resting stage of 
the mosquito ovaries, where the ovaries halt at a length of 100 µm until the mosquito 
takes a bloodmeal (Noriega 2004).  Once bloodfed, JH levels decline, and ecdysone 
levels increase (Dhadialla and Raikhel 1994).  Ecdysone increase initiates the 
development of the mosquito ovarioles into eggs.  Results from prior experiments 
(Chapter 2) indicate that methoprene treatment in adult female Ae. aegypti mosquitoes 
causes a suspension of ovariole development, where ovarioles become halted at the 
resting stage.  Ae. polynesiensis and Ae. albopictus mosquitoes experience a different 
reaction to methoprene treatment, where the chorion of the developing eggs become 
weaker and leak yolk on dissection. While the mosquitoes which experienced this 
reaction were capable of oviposition, the eggs that were laid were unable to hatch.  
Further research could illustrate if this is due to a loss of nutrition from yolk lost during 
egg development. There may be a connection between the treatment reaction of each 
mosquito with the difference between these species in length of development time. 
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Because Ae. polynesiensis and Ae. albopictus have longer development times (personal 
observations), it is possible that they are more capable of compensating for the presence 
of methoprene in the haemolymph. 
When corrected using the Henderson-Tilton formula, there were no significant 
relationships found in mortality between each of the mosquito species studied. This 
relationship is true for both males and females. The absence of significant mortality 
effects is beneficial to the strategy of Altosid® treatments with incompatible releases and 
indicates that treated males will be able to survive sufficient periods to assist the release 
program.   
Increased survival in addition to lowered fecundity indicates the viability of an 
Altosid® treatment to assist Wolbachia SIT.  Before male mosquitoes may be released 
into the environment, they must first be sorted from the females.  Current sorting methods 
are not perfect, and it is possible for female mosquitoes to be missed during the 
separation process (Mains 2012).  By applying a 10% diluted Altosid® solution to sorted 
mosquitoes prior to release, researchers can reduce the potential for fertile females to be 
released into the environment. Results of this research indicate that any male mosquitoes 
exposed to an Altosid® treatment will be capable of maintaining competitive status with 
wild males. Further research should be performed to ascertain the exact physiological 
response of male Aedes mosquitoes to methoprene treatment. Research has not been 
performed to determine the precise role JH has in spermatogenesis, and further research 
could show any chronic effects on male virility, similar to the effects on female 
mosquitoes. Other studies have already indicated that male Wolbachia infected 
mosquitoes are capable of equivalent levels of competition to wild males (Chambers et al 
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2011), and the results of this study indicate that Altosid® treatment has no acute 
detrimental effect on male health and virility.   
By using Altosid®, scientists hoping to control mosquitoes using SIT have a 
simple method to deactivate potentially released females. The method currently described 
by this study uses a diluted form of currently available commercial grade materials, and 
is therefore accessible and not cost prohibitive.  Low cost and ease of use are important 
for SIT releases, due to the large numbers of insects required to establish control.  In the 
case of the Wolbachia biopesticide method, repeated, inundative releases of mosquitoes 
are required in order to establish population control (Alphey et al 2010).  By using Ultra 
Low Volume (ULV) sprays, small amounts of Altosid® could potentially be used to treat 
containers of mosquitoes prior to release. Future studies should ascertain the optimum 
volume container and droplet size for methoprene application to potentially massive 
amounts of mosquitoes.  There is a possibility that mosquitoes which were still capable of 
ovipositing during the course of this project were simply missed by the spray method 
used.  The use of a ULV spray corrects this issue by shrinking the size of the droplets and 
increasing the number of droplets introduced to the atmosphere (Burt and Smith 1974). 
The results described here support additional research in this area. 
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Table 4.1: Ae. aegypti mortality and fecundity measures during Altosid® application 
experiments 
Time Treatment 
% Female 
mortality 
% Male 
mortality 
No. of eggs 
per female 
No. of larvae 
per female 
3 Days 
Acetone 0.0±0.0 8.5±0.3 --- --- 
Water 0.0±0.0 0.0±0.0 --- --- 
 10% Altosid 3.4±4.8 3.3±4.6 --- --- 
 1% Methoprene 43.6±23.1 28.6±14.6 --- --- 
      
10 Days 
Acetone 3.9±5.4 46.9±7.4 --- --- 
Water 24.9±17.2 42.9±8.4 --- --- 
 10% Altosid 24.7±11.4 50.5±27.4 --- --- 
 1% Methoprene 71.8±11.6 70.5±28.9 --- ---- 
      
17 Days 
Acetone 11.5±5.4 57.6±10.8 48.9±37.5 43.7±35.1 
Water 39.6±18.0 62.5±17.3 33.8±25.9 23.5±14.7 
 10% Altosid 49.8±20.6 76.7±26.6 0.6±1.8 0.0±0.0 
 1% Methoprene 87.6±8.1 100.0±0.0 0.0±0.0 0.0±0.0 
 
 
 
 
Table 4.2: Ae. polynesiensis mortality and fecundity measures during Altosid® 
application experiments 
Time Treatment 
% Female 
mortality 
% Male 
mortality 
No. of eggs 
per female 
No. of larvae 
per female 
3 
Days 
Control 10.0±17.3 36.1±24.1 --- --- 
0.1% Altosid 13.3±15.3 36.7±5.8 --- --- 
 1.0% Altosid 27.6±23.7. 46.7±15.3 --- --- 
 10% Altosid 16.7±5.8 38.8±10.2 --- --- 
      
10 
Days 
Control 43.2±24.2 81.7±16.1 --- --- 
0.1% Altosid 46.7±5.8 93.3±5.8 --- --- 
 1.0% Altosid 68.5±11.7 96.7±5.8 --- --- 
 10% Altosid 60.0±20.0 70.9±10.1 --- ---- 
      
17 
Days 
Control 54.6±22.2 97.2±4.8 26.1±13.2 17.0±15.2 
0.1% Altosid 76.7±5.8 96.7±5.8 15.8±9.9 8.4±5.4 
 1.0% Altosid 77.6±15.9 100.0±0.0 0.5±0.9 0.0±0.0 
 10% Altosid 86.7±5.8 100.0±0.0 0.0±0.0 0.0±0.0 
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Table 4.3: Ae. albopictus mortality and fecundity measures during Altosid® application 
experiments 
Time Treatment 
% Female 
Mortality 
% Male 
Mortality 
No. of eggs 
per female 
No. of larvae 
per female 
3 Days Control 23.3±32.5 26.7±17.2 --- --- 
 10% Altosid 9.8±10.0 33.0±30.8 --- --- 
      
10 Days Control 33.3±34.3 69.4±23.4 --- --- 
 10% Altosid 42.4±26.1 78.2±26.9 --- --- 
      
17 Days Control 74.4±28.0 96.3±4.5 30.9 ±8.6 13.7±8.1 
 10% Altosid 65.1±20.5 100.0±0.0 14.8±12.3 2.1±2.3 
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Figure 4.1: Weighted mortality of Altosid® treated mosquitoes, by sex. These numbers 
have been corrected for treatment levels using the Henderson-Tilton equation. Bars show 
standard deviation in mortality between replicates (N = 5).  A) Male mortality B) Female 
mortality 
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Chapter Five 
Conclusion 
Mosquito population control is a vast and daunting goal facing society. 
Methoprene application has the potential to enhance current control measures, and 
perhaps contribute towards long term control of mosquito populations. The experiments 
shown in prior chapters illustrate the potential of methoprene to have chronic effects 
upon female mosquito reproductive capacity.  These chronic effects could be used to 
establish long term mosquito control by supplementing incompatible male release or 
through direct application through aerosol treatment.   
Incompatible male release functions by releasing male mosquitoes artificially 
infected with a symbiont, Wolbachia. These males are incapable of successfully 
producing offspring with any female mosquito that is not infected with the same strain of 
Wolbachia (Werren 1997).  By inundating the wild population with infected males, the 
wild females are effectively prevented from successfully breeding, and the population is 
reduced (Dobson 2003).  Before release, all female mosquitoes must be removed to 
prevent replacement of the wild population with Wolbachia infected females.  The 
current sorting methods use a glass plate to physically separate male pupae from female 
pupae (Mains 2012).  This method is not perfectly effective, and some females can be 
overlooked.  Current measures to prevent this error involve the anesthetization of all the 
mosquitoes prior to release, and physically removing any females.  This method is time 
consuming, and some females could still be overlooked (personal observations).  
Methoprene application prior to release could greatly simplify this process.  The results 
of earlier chapters indicate that a spray composed of 0.1% methoprene would 
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successfully arrest the reproductive development of any missed female mosquitoes, while 
not having any significant effects upon male mortality.   
Methoprene application would significantly reduce the amount of processing 
needed prior to incompatible male release.  Adult mosquitoes could be isolated in cages 
within one room, where a mister system would then treat all cages containing mosquitoes 
at the same time.  Any female mosquitoes contained within would have their reproductive 
capacity significantly reduced, which in turn significantly reduces the chances of 
population replacement.  Also, since methoprene does not have a significant effect upon 
male fitness, methoprene treated incompatible males will still be capable of mating with 
wild females, and will still be capable of effecting wild mosquito population levels. 
In pest control situations, methoprene could function as an air dispersed chronic 
insecticide.  By applying methoprene within an Ultra-Low Volume (ULV) spray, pest 
control technicians could easily treat adult mosquitoes which could not have been easily 
reached using prior methods.  This is particularly important when attempting to control 
Aedes mosquitoes, which breed using small cryptic water sources that are difficult for a 
technician to find (Benedict et al. 2007). There is also a potential for the spray to serve 
the purpose of treating the small water sources where Aedes mosquito larvae live, and 
preventing those larvae from becoming adults.  By simultaneously affecting adult 
fecundity and larval survival, methoprene application could have a significant effect on 
mosquito population size. 
Methoprene is currently commercially available as the active ingredient within the 
liquid larvicide Altosid®, and contains 0.5% methoprene by volume. Altosid® is a 
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pesticide commonly applied by mosquito control agencies, and is inexpensive to acquire 
in comparison to technical grade methoprene. A 10% Altosid® dilution resulted in 0.05% 
methoprene application to adult female mosquitoes, and was shown to effectively reduce 
female mosquito reproduction when applied by spray in prior chapters.   
Liquid Altosid® is currently applied as an aerial spray, but is still for the express 
purpose of treating water sources.  When Altosid® is applied by aerial spray, it is for the 
treatment of fields which have become flooded and mosquito populations have increased 
to the point that civilians have begun to complain.  Aquatic non-target effects have been 
researched for methoprene, but little research has been performed on terrestrial insect 
species due to the constraints of methoprene application.  The aerial treatment method is 
common in crops that use flood irrigation, like rice and dates.  In these cases, non-target 
terrestrial effects are not evaluated, since there are no beneficial insects which are 
considered in these situations.   
This work could be effectively expanded upon by applying an ULV spray to a 
number of insects which naturally occur in settings where the pesticide could be applied, 
in order to ascertain non-target effects of methoprene application.  This could be further 
narrowed to focus on beneficial urban insects, since methoprene treatment would be used 
primarily in urban areas.  Mosquitoes are difficult to control in urban areas, and small 
water sources are common.  Methoprene is already used in urban environments as a 
larvicide to treat man-made bodies of waters which have become infested with 
mosquitoes.  With successful testing, aerial Altosid® application could supplement urban 
control strategies, and greatly decrease mosquito populations in urban environments. 
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ULV application could treat any adults within the treatment area, and prevent female 
mosquitoes from ovipositing outside the treatment area.  
Methoprene application has the potential to assist with multiple strategies of 
mosquito control, both through directly effecting the pest population and by working in 
conjunction with other control methods.  Methoprene is already a part of mosquito 
integrated pest control; however it has the potential to become a much larger part through 
chronic effects.  The long lasting effects discussed in prior chapters, where fecundity is 
significantly reduced for multiple gonotrophic cycles, could contribute to more complete 
control over mosquito populations. Further research is needed before a new methoprene 
application regimen can be implemented, most notably looking at the non-target effects 
of methoprene application in field situations.  
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